How many clinical trials are tracked of Tildrakizumab?

6 trials are tracked, 0 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Ophthalmology Urology Dermatology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Tildrakizumab

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of Tildrakizumab

6 trials tracked of Tildrakizumab: 3 in phase 3 or 4.

6Trials tracked

3Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 4 2 Phase 3 1 Phase 2 2 Other / NA 1

Phase 4 Predicting Inflammatory Skin Disease Response to IL-23 Blockade Completed
Phase 4 MIcrovascular dysfuNction In Moderate-severe Psoriasis Completed
Phase 3 Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis Completed
Phase 2 A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003) Completed
Phase 2 Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease Completed
N/A Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.